FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning
Drug Topics
JANUARY 8, 2025
Patients who receive either Pfizer or GSKs respiratory syncytial virus vaccine may be at increased risk of Guillain-Barr syndrome.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
JANUARY 8, 2025
Patients who receive either Pfizer or GSKs respiratory syncytial virus vaccine may be at increased risk of Guillain-Barr syndrome.
Pharmaceutical Technology
MAY 15, 2024
The US agency rejected the expanded use of Dynavax’s vaccine for adults on haemodialysis, citing insufficient efficacy and safety data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 10, 2021
A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty shot. . It is also asking for similar data from Moderna, which manufacture a COVID-19 vaccine that like Comirnaty is based on mRNA.
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.
Fierce Pharma
OCTOBER 25, 2023
Five months after becoming the first company to secure FDA approval for a respiratory syncytial virus (RSV) vaccine, GSK is taking steps toward expanding its label for Arexvy. The company has revealed that a study investigating Arexvy’s effectiveness in adults ages 50 to 59 has achieved its two primary objectives.
pharmaphorum
MARCH 2, 2021
Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over.
pharmaphorum
AUGUST 25, 2021
Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and its market-leading Prevnar franchise.
pharmaphorum
DECEMBER 16, 2022
Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.
Pharmaceutical Technology
OCTOBER 29, 2024
The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children 2-11 years of age.
Fierce Pharma
JUNE 7, 2024
Thanks to respiratory syncytial virus (RSV) shot Arexvy’s new label expansion into a slightly younger pool of adults, GSK is more confident than ever that its vaccine will be able to conquer the co | The FDA approved Arexvy for RSV prevention in adults ages 50 to 59 who are at increased risk of developing RSV disease.
Pharmaceutical Technology
APRIL 6, 2023
Moderna has announced that its cancer vaccine mRNA-4157/V940 along with Keytruda secured the European Medicines Agency (EMA) Priority Medicines (PRIME) scheme designation for the adjuvant treatment of high-risk stage III/IV melanoma patients after complete resection.
pharmaphorum
MARCH 17, 2021
European regulators are “worried” that national regulators may have undermined trust in the Oxford University/AstraZeneca vaccine by temporarily suspending its use, despite central guidance to keep using it until a safety review has concluded later this week. . Politically motivated?
Pharmaceutical Technology
JULY 25, 2022
The European Commission (EC) has extended Bavarian Nordic ’s smallpox vaccine Imvanex (MVA-BN or Modified Vaccinia Ankara-Bavarian Nordic) marketing authorisation to offer protection from monkeypox. A non-replicating smallpox vaccine, Imvanex was developed in partnership with the US Government.
Pharmaceutical Technology
APRIL 24, 2023
Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.
Pharmaceutical Technology
SEPTEMBER 8, 2022
The list includes providers of development services, biologics management supply chain solutions, clinical trial services, commercial and logistics services, as well as packaging, labelling and distributing services for biologics.
Hospital Pharmacy Europe
MARCH 11, 2025
Professor Nazar adds that when it comes to research into chronic disease management, pharmacist-led studies have been shown to improve medication adherence and reduce hospital readmissions, while public health research involving pharmacists has demonstrated increased vaccination rates and contribution to antimicrobial stewardship.
pharmaphorum
JANUARY 8, 2021
As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.
pharmaphorum
JANUARY 8, 2021
As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.
The Checkup by Singlecare
APRIL 3, 2025
They are kiosks that contain prescription medications, labeling equipment, and technology that can connect the patient to a remote pharmacist in real time. They can accept new or refill prescription orders, store medications, label and prepare prescriptions, and, at the discretion of a remote pharmacist, dispense prescriptions to patients.
pharmaphorum
JANUARY 28, 2021
The Covid-19 pandemic has put further pressure on clinical trial suppliers to be fleet of foot in getting products dispatched when a new patient is recruited, as studies for vaccines have been set up and run at unprecedented speed. . To find out more about the webinar and to register, visit [link] .
pharmaphorum
MAY 26, 2021
Belgium’s Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson’s one-shot COVID-19 vaccine, following the death of a woman from what appeared to be a blood clot-related condition. . Last month, the EU regulator concluded that the benefits of the vaccine still outweigh any risks.
The FDA Law Blog
DECEMBER 3, 2023
The manufacturer’s agreement must cover all its labeler codes that contain an applicable drug or a selected drug. All labeler codes that are covered by Discount Program agreements will be distributed to PDP sponsors and posted on the CMS website. covered insulin product or vaccine). state pharmaceutical assistance programs).
The FDA Law Blog
AUGUST 21, 2023
Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts. A recent state law failure-to-warn case in the SDNY makes that very point.
Pharmacy Is Right For Me
OCTOBER 21, 2022
My evenings involve music production, radio show production, podcast production, reviewing new music sent by labels/music promoters, and preparing for gigs. When the monkeypox outbreak was happening here in NYC, I used my platform to be a source of information about vaccines and TPOXX treatments.
The Checkup by Singlecare
JULY 8, 2024
According to the drug’s label , the most common Rinvoq side effects in people with atopic dermatitis include: Upper respiratory tract infections Acne Herpes simplex Headache Rinvoq may also increase a person’s risk of herpes zoster ( shingles ) and cold sores. It is an injectable.
Hospital Pharmacy Europe
OCTOBER 12, 2022
Molnupiravir treatment for five days improved recovery time in high-risk vaccinated COVID-19 patients but not hospitalisation or death. But whether molnupiravir was of value among those who have been vaccinated was much less clear. had at least one dose of a COVID-19 vaccine and 93% had received three doses of a vaccine.
The Checkup by Singlecare
MAY 24, 2024
Its use in cats is “off-label,” meaning that the U.S. Azithromycin ( brand name Zithromax ) is a commonly used antibiotic that treats a broad spectrum of bacterial infections in cats, including skin infections, upper respiratory tract infections , pneumonia, bronchitis, and blood infections.
The People's Pharmacy
MAY 29, 2023
According to my European colleagues it is prescribed off-label for this purpose. A reader of this column notified us several years ago that his medical colleagues in Europe prescribed cimetidine off label to treat shingles and z oster- a ssociated p ain ( ZAP ). We searched high and low for research to support this unique strategy.
Hospital Pharmacy Europe
JANUARY 8, 2023
Molnupiravir treatment failed to reduce both COVID-related hospitalisation and mortality among high-risk vaccinated adults in the community. But with millions of individuals now vaccinated against COVID-19, it remains uncertain whether molnupiravir treatment is still an effective option in such patients. Lancet 2022.
IDStewardship
JULY 27, 2022
At the same time, there were multiple competing priorities, such as managing the bone infection caseloads, implementing changes to departmental IPC practice, vaccination programmes and new COVID-19 treatments. Like all AMS teams, trying to be agile and respond to this change has been an enormous challenge.
pharmaphorum
SEPTEMBER 15, 2020
As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus. There was a pressing need to successfully adapt materials at speed for MLR approval – rewriting labels for changing medical needs, adapting and shifting materials to send different messages, and so on.
pharmaphorum
MARCH 15, 2022
During the first half of 2020, surveys indicated that doctors would be reluctant to attend physical meetings in 2021, indicating preferences based mainly on fear of contracting COVID-19 and availability of vaccines. yes, if vaccines are available; 15.8% The ‘hybrid’ label is confusing. Results from 335 responses were: 47.8%
The Checkup by Singlecare
MAY 16, 2024
Healthcare providers sometimes prescribe it for off-label uses as well, including for severe forms of sarcoidosis, pustular psoriasis, and COVID-19. The FDA has placed boxed warnings on Remicade’s drug label , calling attention to the risk of serious infections, like tuberculosis and fungal infections.
The Checkup by Singlecare
SEPTEMBER 13, 2024
Frequency Headache Yes 8% Yes 19% Injection site reaction Yes 2% Yes 8% Back pain No Yes 5% Sore throat Yes 5% Yes 3% Fever Yes 3% Yes 3% Source: Fasenra drug label and Nucala drug label Fasenra and Nucala drug interactions No drug interactions are posted on the labels for Fasenra or Nucala.
pharmaphorum
OCTOBER 7, 2021
That is of paramount importance in medical education, “where a lot of the discussions between the KOLs in the sessions are about off-label content.” ” That means providers have to make sure that they exclude HCPs from countries that aren’t allowed to get off-label content directly from a pharma company.
The Checkup by Singlecare
APRIL 3, 2024
This can reduce stomach upset unless your medication is labeled “enteric coated” or “gastro-resistant.” Keep up-to-date on vaccines as recommended by your provider. ” These may be taken without food. Take it in the morning. These medications may interfere with prednisone.
The Checkup by Singlecare
JULY 11, 2024
The drug’s label recommends doses of 5–60 mg per day. So, anyone taking it should avoid people who have highly infectious diseases like the flu or who recently received a live vaccine. Prednisone is available in two forms: oral medication and injection.
European Pharmaceutical Review
FEBRUARY 13, 2023
This is like antigens which can trigger an immune response and act as a vaccine. Firstly, using liquid chromatography and mass spectrometry, they carry out a systematic comparison of different fragments of a mRNA molecule to be tested with a similarly fragmented reference mRNA labelled with a stable carbon isotope.
The Checkup by Singlecare
APRIL 21, 2023
Another option is to bring your empty, labeled prescription bottle to the new pharmacy or use their mobile app to request a transfer. Even if you have an insurance plan that prefers a certain in-network pharmacy, you may be able to use a pharmacy discount app , like SingleCare, to save money without insurance at an out-of-network pharmacy.
Pharmaceutical Technology
JULY 29, 2022
The open-label, three-cohort, multicentre trial analysed intravesical BCG, N-803 combination in BCG-unresponsive high-grade NMIBC patients. In January, ImmunityBio and Amyris have concluded a joint venture (JV) agreement announced previously to accelerate the marketing of a Covid-19 vaccine.
pharmaphorum
MAY 17, 2021
Apellis Pharma has secured FDA approval for its complement C3 inhibitor Empaveli as a treatment for paroxysmal nocturnal hemoglobinuria (PNH) – with a label that will allow it to challenge Alexion’s established therapies directly. .
The Checkup by Singlecare
OCTOBER 30, 2023
Amoxicillin food interactions According to the amoxicillin product labeling , there are no drug-food interactions of concern. Amoxicillin and oral live vaccines Antibacterial drugs such as amoxicillin can impact the effectiveness of the oral typhoid and cholera vaccines.
The Checkup by Singlecare
JULY 12, 2024
Xolair’s drug label includes a disclaimer that an omalizumab injection may cause a serious or life-threatening allergic reaction. That includes live vaccines such as MMR, varicella, rotavirus, and the intranasal flu vaccine. The most common side effects of Xolair are injection site reactions, joint stiffness, and body aches.
pharmaphorum
JUNE 24, 2022
Before the monkeypox outbreak, really, only the US and Canada had stockpiled our drug and very few people had actually stockpiled the vaccine between Canada, the US, and a few other countries,” Siga CEO Phil Gomez told pharmaphorum. “So I was part of the team that worked on the first SARS vaccine that went into humans.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content